What’s New in FDA’s Final Guidance Documents for Drug and Device Manufacturer Communications

Please join our experienced panel for a review of FDA’s most recent final guidance documents on drug and device manufacturer communications:

• Medical Product Communications That Are Consistent With the FDA-Required Labeling – Questions and Answers
• Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities – Questions and Answers

This will be an informative presentation and discussion about the legal and regulatory history of these guidances, how the final guidances differ from their draft versions, and what the final guidances mean for your communication strategies.

CONTINUING LEGAL EDUCATION CREDIT

CLE credit will be applied for in CA, GA, IL, NY, TX and, if needed, NC and VA. Attendees will receive a Uniform Certificate of Attendance via email approximately 30 days after the program to seek CLE credit in other jurisdictions. New York lawyers: This program is considered transitional and non-transitional in content. The interactive webinar format is synchronous and approved for all lawyers. King & Spalding LLP / 1180 Peachtree Street, Atlanta, GA 30309 | CA Provider # 10947.